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Burkitt’s Lymphoma/Leukemia in a 
15-Year-Old Male 
Tanakorn Songrug, Brent A. Adler, M.D., and Samir B. Kahwash, M.D.
We present the case of a 15-year-old male with sporadic Burkitt’s lymphoma/leukemia. The pa-
tient presented with right lower quadrant abdominal pain and masses in the terminal ilium and 
pelvis, and was subsequently demonstrated to have involvement of the bone marrow. We discuss 
differential diagnoses and approach to diagnose and stage this disease. A review of the clinical, 
radiologic, and pathologic features of Burkitt’s lymphoma/leukemia are also presented.
Burkitt’s lymphoma was described in 1958 by Den-
nis Burkitt in Africa [1]. It is a malignancy arising from 
mature B-cell lymphocytes and one of the most rapidly 
proliferating neoplasms known with doubling time of 
only about 25 hours [2]. The World Health Organiza-
tion Classification of Lymphoid Neoplasms lists three 
clinical variants: endemic, sporadic, and immunode-
ficiency-associated [3]. Endemic Burkitt’s lymphoma 
refers to the cases that occur in equatorial Africa, usually 
Introduction in children 4-7 years old, and often involving the jaws 
and other facial bones with less involvement of the 
abdominal organs [2]. Epstein-Barr virus is involved in 
nearly all endemic cases [4]. Sporadic Burkitt’s lympho-
ma/leukemia often involves the abdomen, especially the 
ileocecal area. However, the ovaries, kidneys, omentum, 
Waldeyer’s ring, breast and other sites may be involved 
as well. The sporadic form occurs worldwide with no 
specific geographic or climate predilection. Within the 
U.S. and Western Europe, the sporadic form accounts 
for 1%-2% of all adult Lymphoma and 40% of Lym-
phoma in children [2]. Immunodeficiency-associated 
Burkitt’s lymphoma primarily occurs in HIV patients, 
allograft recipients, and individuals with congenital 
immunodeficiency. By convention, the term Burkitt’s 
Leukemia is used when Burkitt’s blasts are present in the 
bone marrow at 20% or more.
A previously healthy 15-year-old Caucasian male 
presented with a 5-week history of intermittent right 
lower quadrant abdominal pain, non-bilious emesis, 
constipation, and low grade fevers with accompanying 
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Figure 1. 15-year-old male with Burkitt’s lymphoma. 
Abdominal radiograph shows mucosal thickening in a loop 
of bowel in the patient’s right hemipelvis. There is a soft 
tissue fullness overlying the right sacroiliac joint that may 
represent a mass. Moderate amount of stool and gas are 
presented in the ascending and transverse colon with no 
evidence of obstruction or calcification.
night sweats and chills. The patient denied chest pain or 
tightness, palpitation, or dyspnea. Prior to this illness, 
he had no significant past medical history and took no 
medication. His only previous surgery or hospitalization 
was tympanostomy tube placement when he was 6 years 
old. His symptoms were initially attributed to infectious 
gastroenteritis. However, his symptoms continued to 
progress and he had reportedly lost about 15 lb. over the 
course of this illness. He had one episode of large bloody 
stool with diarrhea 2 days prior to hospital admission.
On physical exam, the abdomen was soft and dis-
tended with a mass in the right lower quadrant that was 
tender on deep palpation. No hepatosplenomegaly was 
apparent. There was no palpable cervical, supraclavicular 
or inguinal lymphadenopathy. There was also no focal 
neurological deficit. Other physical exam findings were 
Figure 2. Chest radiograph shows normally inflated lungs 
without evident hilar adenopathy. There is some blunting of 
the right costophrenic angle (arrow).
unremarkable.
Initial laboratory investigation revealed a white 
blood count of 3.7 x 103/mm3, hemoglobin of 10.9 g/
dL, platelet count of 159 x 103/mm3, elevated Lactate 
dehydrogenase (LDH) and uric acid at 2313 U/L and 
of 8.9 mg/dL respectively. Other chemistries and liver 
function tests were within normal limits.
A radiograph of the abdomen demonstrated soft 
tissue fullness overlying the right sacroiliac joint and 
mucosal thickening in a loop of bowel in the right pelvis 
(Fig. 1). There was no evidence of obstruction or calcifi-
cation. Chest radiograph (Fig. 2) demonstrated blunt-
ing of the right costophrenic angle thought to be due 
to either pleural thickening or pleural fluid. There was 
no apparent adenopathy. Chest computed tomography 
(CT) with contrast confirmed small right pleural effu-
sion with small superior/anterior mediastinal adenopa-
thy, a small nodule at the right base of the lung near the 
diaphragm, and no hilar adenopathy.
Abdominal/Pelvis CT with contrast showed a large 
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Figure 3. CT with contrast. (A) The bulky 
heterogenous mass (M) measured 6 cm. 
in AP dimension and 7 cm in transverse 
dimension. Contrast material from the 
lumen of the bowel is seen around it, 
suggesting that the mass arises from the 
bowel wall. (B) A smaller mass (M) in the 
patient’s pelvis located left of the rectum 
and posterior to the bladder. It measures 
5.8 cm in transverse dimension, 4.2 cm in 
AP dimension. (C)Coronal reconstruction of 
the Abdominal/Pelvis CT. The right lower 
quadrant mass (M), measured 12 cm in 
Superior-Inferior (SI) dimension, appears 
to infiltrate the bladder wall and displaces 
it from left to right. There is a tubular 
structure (arrow) that is seen extending 
from the large mass and draping over the 
colon. This may represent an infiltrated 
and enlarged appendix. There is abnormal 
thickening of the diaphragm adjacent to the 
liver (*).
A
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C
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heterogenous mass (Fig. 3A) infiltrating the wall of the 
terminal ileum, cecum and mesentery with evidence 
of metastasis to the omentum, the diaphragm and the 
pelvis. The mass did not cause obstruction and contrast 
material was clearly seen into the colon. A smaller mass 
was also identified in the pelvis posterior to the blad-
der (Fig. 3B). There was no evidence of bowel perfora-
tion because no extravasation of contrast material was 
seen outside the bowel. A small amount of free fluid 
was noted in the pelvis and abdomen along with small 
lymph nodes along the diaphragm on the thoracic side.
Percutaneous needle biopsy of the mass of the right 
lower quadrant was performed under ultrasound guid-
ance. Pathologic examination (Fig. 4B) demonstrated 
sheets of small to medium size lymphoid cells. The cells 
displayed scanty cytoplasm with brisk mitotic rate. The 
lymphoid cells were interposed with cellular debris-
laden macrophages creating a starry-sky pattern classi-
cally associated with Burkitt’s Lymphoma/Leukemia. 
Immunohistochemical stains (Fig. 5) were positive for 
CD45 or leukocyte common antigen (LCA). Mark-
ers for B-lymphocyte CD20, and CD79a, were also 
positive, while the Pan T-cell marker CD3 was negative. 
Our sample was predominantly positive for kappa and 
negative for lambda light chain, indicating monoclonal-
ity which supports a neoplastic proliferation. Further 
studies revealed involvement within the bone marrow 
Figure 4. Hematoxylin and eosin (H&E) stained microscopic images from bone marrow aspiration clot (A) and from mass in 
the right lower quadrant (B) demonstrating sheets of medium size lymphoid cells with high mitotic activity interspersed with 
macrophage forming “starry-sky” pattern.
(Fig. 4A), at 42% of marrow cells, making the diagnosis 
of Burkitt’s Leukemia (rather than Lymphoma) more 
applicable. Traditionally, this extensive bone marrow 
involvement means that the diagnosis can be classified 
as L3 acute lymphoblastic Lymphoma/Leukemia (FAB 
[French-American-British] L3 ALL). However, accord-
ing to the World Health Organization (WHO) Clas-
sification of Lymphoid Diseases, the Lymphoma and 
leukemic phases of the disease are classified as a single 
entity; a mature B-cell neoplasm, with subtype Burkitt’s 
Lymphoma/Burkitt’s cell Leukemia [3]. There was no 
evidence of leukemia in the cerebrospinal fluid.
For staging, a positron emission tomography (PET) 
study was performed with the injection of F-18 labeled 
fluorodeoxyglucose (FDG). The results demonstrated 
extensive FDG accumulation in the area of the domi-
nant mass and increased FDG accumulation along the 
pericolic gutters. There were multifocals bone uptakes 
within the vertebral bodies, the long bones of the upper 
and lower extremities, several ribs, and sternum. This 
finding suggested diffuse bony metastases. The extensive 
bone marrow involvement suggested that the patient 
was in stage IV of the St. Jude/Murphy Staging System 
for Burkitt’s Lymphoma/Leukemia [2].
With pathologic confirmation, the patient un-
derwent cytoreductive phase therapy (COP) with 
cyclophosphamide, vincristine, and prednisone with 
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Figure 5. Immunohistochemical stains showing positive leukocyte common antigen (A), CD20 (B), CD79a (C), Kappa light 
chains (D), negative Lambda light chains (E) and Diff-Quick stained Touch prints cytology (F).
intrathecal methotrexate and hydrocortisone. Induction 
therapy was then employed with COPADM1 regiment 
consisting of cyclophosphamide, vincristine, prednisone, 
doxorubicin and high-dose methotrexate. The patient 
tolerated the chemotherapy well and showed clinical and 
radiological improvement.
Abdominal/Pelvis CT with contrast [Fig. 6] two 
months after initiation of chemotherapy revealed that 
the original mass which involved the terminal ileum and 
cecum is now seen as two discrete masses. The superior 
mass involved the mesentery located just superior to 
the terminal ileum [Fig. 6A] while the other is at the 
terminal ileum itself [Fig. 6B]. Surrounding them are a 
number of lymph nodes that may have been involved 
in the previous consolidated mass. The two masses 
combined displayed significant reduction in size when 
compare to the previous study. The superior mass also 
displayed interval central necrosis suggesting response 
to therapy. The mass in the pelvis [Fig.6C] was also 
significantly decreased in size. In addition, there was a 
significant decrease in the amount of thickening seen 
along the peritoneal cavity, particularly the diaphragm, 
and a decrease in the infiltration of the omentum when 
Lymphoma is the most common malignancy of the 
small bowel and often presents as bowel wall thicken-
ing or dilatation of the bowel lumen [5]. Many types of 
Lymphoma can involve the small bowel, but most cases 
are due to non-Hodgkin’s lymphoma. The terminal il-
eum, with the greatest concentration of lymphoid tissue, 
is the most common site of small bowel B-cell lym-
phoma. In our case, Burkitt’s lymphoma was thought to 
be the most likely diagnosis due to the location and size 
of the dominant mass at presentation, the age of onset 
of this patient as well as the clinical presentations. Other 
etiologies such as adenocarcinoma, desmoid tumor, 
and sarcomas were also considered, although they were 
thought to be significantly less likely. The soft tissue 
sarcomas and neuroblastoma are primarily retroperi-
toneal tumors and ascites is not commonly associated 
with either diagnosis [6]. Obstruction is uncommon in 
small bowel lymphoma because the mass is usually soft 
and pliable but it is more common in adenocarcinoma. 
Discussion
compared to the previous study.
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Figure 6. Two months after 
initiation of chemotherapy. 
(A) The superior mass (M) 
measured 50 mm in transverse 
dimensions, 39 mm in anterior-
posterior dimension. Compared 
to the previous study, the 
mass showed interval decrease 
in size and increase in the 
amount of central low attenu-
ation consistent with increased 
tissue necrosis. (B) The inferior 
mass (M) associated with the 
terminal ileum now measured 
approximately 29 mm in trans-
verse dimension, 23 mm in an-
terior-posterior dimension. The 
lumen of the terminal ileum is 
discernible in this study. Some 
discreet lymph nodes are seen 
around the mass (arrows). 
(C) The previously seen pelvic 
mass shows significant reduc-
tion in size. In this study, only 
minimal amount of enhancing 
soft tissue (M) measuring ap-
proximately 10 mm in thickness 
is appreciated.
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Desmoid tumor arises from fibroblastic proliferation 
originating from fascia and muscle aponeurosis that pri-
marily involves the anterior abdominal wall [7]. Classi-
cally, the disease is more common in females, in patients 
with history of trauma (often surgical) to the site of the 
tumor [8], and in patients with familial polyposis of the 
colon [9]. Our case shares none of these characteristics. 
In addition, mucinous carcinoma of the appendix could 
also create the peritoneal metastasis observed in the 
abdominal CT. However, primary appendiceal malig-
nancy is rare and makes up of only about 0.5% of all 
intestinal tumors [10]. In addition, the majority of the 
appendiceal malignancies are carcinoid tumors that do 
not present as a bulky mass.
Burkitt’s lymphoma/leukemia is a rare form of 
cancer in the United States. The incidence is reported 
as about 0.3 - 0.5 per 100,000-years [11]. Interestingly, 
the incidence is steadily increasing as demonstrated in 
a study of its incidence from 1945 to 1995 in central 
Ohio [12] and recently the overall incidence in the 
US is increasing at about 8% per year from 1991 to 
2001 [13]. Patients with sporadic Burkitt’s lymphoma/
leukemia often present with abdominal pain, nausea, 
vomiting, gastrointestinal bleeding, and other syn-
dromes mimicking acute appendicitis or intussusception 
[2]. Patients may quickly manifest significant metabolic 
derangement and renal function impairment due to the 
rapid growth of the tumor. At diagnosis, patents often 
have bulky mass and elevated uric acid as well as lactate 
dehydrogenase. In adults, bone marrow involvement 
is found in 30-38% and 13%-17% are found to have 
central nervous system involvement [2].
CT remains the most useful imaging modality in 
diagnosing and assessing the disease stage in gastroin-
testinal lymphomas. Small bowel B-cell Lymphoma in 
general may appear as a bulky mass in the intestinal 
wall with extension into the small bowel mesentery and 
regional lymph nodes (as in our case) or as aneurysmal 
dilation of the lumen due to replacement of the mus-
cularis propria and destruction of the autonomic nerve 
plexus by lymphoma [5]. Abdominal and pelvic masses 
are the most common finding in sporadic Burkitt’s 
lymphoma [6,14]. In one study, the combination of 
intraperitoneal mass, with or without ascites, intraperi-
toneal adenopathy but sparing of retroperitoneal nodes 
is a very strong indication of Burkitt’s Lymphoma [6].
Morphologically, neoplastic cells of classic Burkitt’s 
lymphoma/leukemia are uniform and medium sized 
with round nuclei, moderate size cytoplasm, and high 
mitotic rate. Characteristically, the starry -sky pattern 
is described due to numerous admixed tingible body 
macrophages with abundant phagocytosed apoptotic 
debris within their cytoplasm [2]. Endemic and sporadic 
Burkitt’s lymphoma/leukemias typically have this classic 
morphology. Immunodeficiency associated Burkitt’s 
lymphoma/leukemia often has plasmacytoid differentia-
tion [4]. All variant of Burkitt’s lymphoma/leukemia 
express monotypic surface IgM, pan-B-Cell antigens, 
including CD19, CD20, CD22, and CD79a, and 
coexpress CD10, Bcl-6, CD43, and p53, but not CD5, 
CD23, Bcl-2, CD138 or TdT [2].
A hallmark of Burkitt’s lymphoma/leukemia is the 
translocation of c-myc gene, a transcription factor that 
influences transcription of proteins involved in cell cycle 
regulation, apoptosis, cell growth, cell adhesion, and 
differentiation [2]. Eighty percent of cases of Burkitt’s 
lymphoma/leukemia are found to have translocation 
between chromosome 8 and 14, t(8;14), resulting in 
juxtaposition of the c-myc gene with IgH gene. The 
remaining 20 percent have either t(2;8) or t(8;22) which 
places the c-myc gene close to either the kappa or the 
lambda light chain gene [2]. This rearrangement results 
in cells being in a perpetual proliferative state [4].
Due to the high growth rate of Burkitt’s lymphoma/
leukemia, standard treatment employs short-duration, 
intensive, combination chemotherapy. There are several 
regiments, but common agents include cyclophosph-
amide, vincristine, methotrexate, doxorubicin, and 
cytarabine. Central nervous system prophylaxis with 
intrathecal chemotherapy is required for treatment 
in most adults and not uncommon in disseminated 
pediatric cases. Burkitt’s lymphoma/leukemia is quite 
chemosensitive even in patients with central nervous 
system or bone marrow involvement [2]. With inten-
sive chemotherapy, children with localized disease have 
over 90% 5-year survival rate [15] while children with 
widespread disease (including leukemic presentation) 
may achieve over 90% complete response rate [16]. In 
adult, complete response rates of 65%-100% and overall 
survival rates of 50%-70% have been reported [4].
In terms of imaging follow up, patients with bulky 
abdominal masses who failed to have complete ra-
diographic resolution may require repeated biopsy or 
imaging with positron emission tomography or gallium 
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